about
Phototoxicity to tetrazepam - A new adverse reactionMechanisms of peripheral tolerance to allergensAtopic eczema and other manifestations of atopy: results of a study in East and West Germany.Association study of mast cell chymase polymorphisms with atopy.Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults.[Diagnosis of major sexually transmitted infections in the doctor's office: ectoparasites and yeasts]The wide spectrum of clinical expression in Adams-Oliver syndrome: a report of two cases."Eco-syndrome" ("multiple chemical sensitivity"--MCS).Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology.Epidemiology of acne in the general population: the risk of smoking.Dihydroxyacetone in a new formulation--a powerful therapeutic option in vitiligo.Why are allergies increasing?Multistep navigation of Langerhans/dendritic cells in and out of the skin.Environmental pollution and allergy.Alternative medicine in allergies - prevalence, patterns of use, and costs.A naturally occurring opioid peptide from cow's milk, beta-casomorphine-7, is a direct histamine releaser in man.Neuroimmune interactions in the skin.[Acquired hyalinosis cutis et mucosae in plasmacytoma with monoclonal IgG-lambda gammopathy]Atopic eczema: role of microorganisms on the skin surface.Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum.Atopic eczema: what's new?[Ichthyosis vulgaris, growth retardation, hair dysplasia, tooth abnormalities, immunologic deficiencies, psychomotor retardation and resorption disorders. Case report of 2 siblings]H1- and H2-antagonists in allergic and pseudoallergic diseases.Histamine, antihistamines and atopic eczema.[Diagnosis of major sexually transmitted infections in the doctor's office: bacterial infections]Food allergy and atopic eczema.Atopisches EkzemGINIplus und LISAplus. Design und ausgewählte Ergebnisse zweier deutscher Geburtskohorten zum natürlichen Verlauf atopischer Erkrankungen sowie deren Determinanten
P50
Q28290643-78260E15-FE2A-4146-A440-7A35D4CF921CQ29027397-9B04AEE5-AE01-45A7-9E57-B17B12439068Q30321361-6C2B71FF-36D3-4D01-AC9D-E27BF84C7E4FQ30797518-F00BCA2D-61E9-4F00-94FD-00B8788AC45BQ31108758-034E266A-1707-4C3D-B9B4-D292731A15EEQ31144254-9E825A84-867D-47D7-9754-BBDD9B47D1F2Q33650158-B50AE725-233F-48CF-A0CC-F98098BAE856Q33743979-4A2C7161-0707-49F9-AB63-0B3C25343A5FQ33928948-71D12C15-4397-4D0C-848D-879362C7D8ADQ34083953-86746394-3E16-46D7-B19C-AB75ADA687C6Q34101109-F5A24902-F33D-4DC3-9950-DE1155E88F6AQ34418075-82E244FB-F68B-422A-A464-5D188ED4864CQ34427002-34FDA92D-E2CC-4B61-9646-79359F01F7D3Q34480380-C67DBBA3-B063-4E8F-A0A4-1E22A971A10FQ34525351-E6093FDE-EF3F-4ECE-9F8C-888C2CCE922FQ34539685-B73F8CE3-9DC8-47E7-A16F-FE708DB83929Q34607795-B3C24F2F-DFD6-41A1-A278-B5297CA5B0B1Q35196156-70ADD818-6AB1-4024-898E-F17FB8371721Q35534261-0431C534-3D06-4D51-BDDB-260238C26EBDQ36305883-50D797DD-8929-41B6-9104-297E79CA9C37Q36473293-0CE29915-76DC-451C-8225-58E1EB350AB7Q36655885-217178EE-C730-428C-8369-6DF5F94393F6Q37602191-45114934-C6FE-4D13-B295-A03E08A8B19DQ37609762-0175452A-079C-4483-A312-0107599E1EB1Q37865626-0F041556-872F-422F-A0A1-CDC158FB664FQ37954228-C338B234-2527-44E2-9800-87D7471E94B8Q57072087-972DB4C2-318E-4959-82B3-EC3E51B35E60Q63352974-D9AECE4A-DA7D-4534-A660-6EEFDD925668
P50
description
Duits allergoloog
@nl
researcher from Department of ...... ity of Munich, Munich, Germany
@en
name
J. Ring
@nl
J. Ring
@sl
Johannes Ring
@en
type
label
J. Ring
@nl
J. Ring
@sl
Johannes Ring
@en
prefLabel
J. Ring
@nl
J. Ring
@sl
Johannes Ring
@en